USPTO serial 79287058
EXPERIMENT X
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 22, 2021
- Examiner
- SABAGH, LAILA TAREK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with EXPERIMENT X?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark D. Simpson
Mark D. Simpson Saul Ewing Arnstein & Lehr LLC1500 Market StreetCentre Square West, 38th FloorPhiladelphia, PA 19102Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic reagents for medical use; diagnostic reagents for medical use, namely, for screening testing, analyzing and monitoring of biological material; diagnostic reagents for medical use, namely, for immunoassays, lateral flow immunoassays, multiplex immunoassays, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices, polymerase chain reaction devices; diagnostic substances for medical use for sale in kit form; diagnostic scanning agents for in-vitro medical use; diagnostic testing reagents for testing of body fluids for medical use; diagnostic preparations for medical and veterinary purposes; chemical reagents for medical and veterinary purposes | ACTIVE | — |
| 009 | Downloadable and recorded computer software for medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; Downloadable and recorded computer software for machine learning or artificial intelligence based medical diagnostics; computer hardware for personal medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; downloadable mobile applications for personal medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; downloadable and recorded computer software for the control of medical apparatus, instruments, equipment and devices; downloadable and recorded computer software for the control of medical apparatus, instruments, equipment and devices, namely immunoassays, lateral flow immunoassays, multiplex immunoassays, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices | ACTIVE | — |
| 010 | Medical apparatus, instruments, equipment and devices, namely devices for medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; medical apparatus, instruments, equipment and devices, namely point-of-care devices for medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; medical apparatus, instruments, equipment and devices, namely, immunoassay readers, lateral flow immunoassay readers, multiplex immunoassay readers, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices; medical testing kits, namely medical testing kits including immunoassays, lateral flow immunoassays, multiplex immunoassays, and microfluidics; diagnostic apparatus and instruments for screening testing, analyzing and monitoring of biological material | ACTIVE | — |
| 042 | Software design and development; design and development of software for medical diagnostics, health tracking, telemedicine, telehealth; design and development of software for screening testing, analyzing and monitoring of biological material; design and development of software for immunoassay readers, lateral flow immunoassay readers, multiplex immunoassay readers, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices; design and development of computer hardware; design and development of computer hardware for medical diagnostics, health tracking, telemedicine, telehealth; design and development of computer hardware for screening testing, analyzing and monitoring of biological material; design and development of computer hardware for immunoassay readers, lateral flow immunoassay readers, multiplex immunoassay readers, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices; research, design, development, technological consultancy, and engineering services relating to medical apparatus, instruments, equipment and devices; research, design, development, technological consultancy, and engineering services relating to immunoassay readers, lateral flow immunoassay readers, multiplex immunoassay readers, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices; research, design, development, and technological consultancy services relating to biomarker discovery; providing temporary use of non-downloadable cloud accessible software for medical diagnostics, health tracking, telemedicine and telehealth; cloud computing services for medical diagnostics, health tracking, telemedicine, and telehealth | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Experiment X Ltd
- Other trademarks owned by Experiment X Ltd
- Other trademarks owned by Experiment X Ltd
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named EXPERIMENT X
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 12, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 12, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 22, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 22, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 6, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 6, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 5, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 26, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 26, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 26, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 26, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 26, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 10, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 10, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 10, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 3, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 2, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |